Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.

Columnist Ahna Crum relates her years-long struggle with avascular necrosis, the reason she has a "bone to pick" with ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

Relapsing-remitting multiple ... relapses of new or worsening MS symptoms. These relapses can last for days or months until symptoms slowly improve, with or without treatment.

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

Graham has had a “crash course in MS” after his diagnosis last year, and is willing to do “whatever it takes” to raise funds ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...